The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer

por Brown, Janet E, Coleman, Robert E
Publicado 2002

Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases

por Wood, Steven L., Brown, Janet E.
Publicado 2020

Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone

por Brown, Janet E, Westbrook, Jules A, Wood, Steven L
Publicado 2019

Bone Health in Men with Prostate Cancer: Review Article

por A M El Badri, Salma, Salawu, Abdulazeez, Brown, Janet E
Publicado 2019

Myeloma Bone Disease: The Osteoblast in the Spotlight

por Andrews, Rebecca E., Brown, Janet E., Lawson, Michelle A., Chantry, Andrew D.
Publicado 2021

Complications of bone metastases from malignant melanoma

por Zekri, Jamal, Marples, Maria, Taylor, Dominic, Kandukurti, Kiran, McParland, Lucy, Brown, Janet E.
Publicado 2017

The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo

por Saleh, Lubaid, Ottewell, Penelope D., Brown, Janet E., Wood, Steve L., Brown, Nichola J., Wilson, Caroline, Park, Catherine, Ali, Simak, Holen, Ingunn
Publicado 2023

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer

por Zhong, Jim, Palkhi, Ebrahim, Buckley, David L., Collinson, Fiona J., Ralph, Christy, Jagdev, Satinder, Vasudev, Naveen S., Swain, Jayne, Brown, Janet E., Wah, Tze Min
Publicado 2021

Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-contro...

por Coleman, Robert E., Lipton, Allan, Costa, Luis, Cook, Richard J., Lee, Ker-Ai, Saad, Fred, Brown, Janet E., Terpos, Evangelos, Major, Pierre P., Kohno, Norio, Smith, Matthew, Body, Jean-Jacques
Publicado 2013

CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment

por Westbrook, Jules A., Cairns, David A., Peng, Jianhe, Speirs, Valerie, Hanby, Andrew M., Holen, Ingunn, Wood, Steven L., Ottewell, Penelope D., Marshall, Helen, Banks, Rosamonde E., Selby, Peter J., Coleman, Robert E., Brown, Janet E.
Publicado 2016

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

por Brown, Janet E., Handforth, Catherine, Compston, Juliet E., Cross, William, Parr, Nigel, Selby, Peter, Wood, Steven, Drudge-Coates, Lawrence, Walsh, Jennifer S., Mitchell, Caroline, Collinson, Fiona J., Coleman, Robert E., James, Nicholas, Francis, Roger, Reid, David M., McCloskey, Eugene
Publicado 2020

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

por Stopeck, Alison T., Fizazi, Karim, Body, Jean-Jacques, Brown, Janet E., Carducci, Michael, Diel, Ingo, Fujiwara, Yasuhiro, Martín, Miguel, Paterson, Alexander, Tonkin, Katia, Shore, Neal, Sieber, Paul, Kueppers, Frank, Karsh, Lawrence, Yardley, Denise, Wang, Huei, Maniar, Tapan, Arellano, Jorge, Braun, Ada
Publicado 2015

Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer

por Westbrook, Jules A, Wood, Steven L, Cairns, David A, McMahon, Kathryn, Gahlaut, Renu, Thygesen, Helene, Shires, Mike, Roberts, Stephanie, Marshall, Helen, Oliva, Maria R, Dunning, Mark J, Hanby, Andrew M, Selby, Peter J, Speirs, Valerie, Mavria, Georgia, Coleman, Robert E, Brown, Janet E
Publicado 2019